What is William Blair's Forecast for USPH FY2024 Earnings?

U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) - Equities research analysts at William Blair cut their FY2024 earnings per share (EPS) estimates for U.S. Physical Therapy in a note issued to investors on Tuesday, November 5th. William Blair analyst J. Haase now anticipates that the company will earn $2.67 per share for the year, down from their previous estimate of $2.74. The consensus estimate for U.S. Physical Therapy's current full-year earnings is $2.58 per share. William Blair also issued estimates for U.S. Physical Therapy's Q4 2024 earnings at $0.74 EPS, Q1 2025 earnings at $0.59 EPS, Q2 2025 earnings at $0.81 EPS, Q4 2025 earnings at $0.81 EPS and FY2025 earnings at $3.12 EPS.

Other equities analysts have also recently issued reports about the stock. StockNews.com upgraded shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Wednesday, August 21st. Barrington Research reiterated an "outperform" rating and set a $108.00 price target on shares of U.S. Physical Therapy in a report on Thursday. Finally, Bank of America reissued a "neutral" rating and set a $90.00 price target (down from $114.00) on shares of U.S. Physical Therapy in a research report on Monday, October 7th.

U.S. Physical Therapy Trading Down 1.9 %

Shares of U.S. Physical Therapy stock traded down $1.80 during trading on Thursday, hitting $95.30. The stock had a trading volume of 132,955 shares, compared to its average volume of 91,441. U.S. Physical Therapy has a 1 year low of $76.18 and a 1 year high of $113.63. The stock has a 50 day simple moving average of $83.21 and a 200 day simple moving average of $91.53. The company has a quick ratio of 1.88, a current ratio of 1.88 and a debt-to-equity ratio of 0.28. The company has a market capitalization of $1.44 billion, a PE ratio of 90.46, a P/E/G ratio of 3.93 and a beta of 1.38.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share for the quarter, missing analysts' consensus estimates of $0.82 by ($0.09). The company had revenue of $167.19 million during the quarter, compared to analyst estimates of $163.34 million. U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. The company's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter last year, the business earned $0.76 EPS.

U.S. Physical Therapy Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 15th will be paid a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.85%. The ex-dividend date of this dividend is Friday, November 15th. U.S. Physical Therapy's dividend payout ratio (DPR) is presently 166.04%.

Insider Buying and Selling

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of the company's stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total value of $142,230.00. Following the transaction, the chief operating officer now directly owns 7,038 shares of the company's stock, valued at $580,635. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, COO Graham D. Reeve sold 1,724 shares of the firm's stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total transaction of $142,230.00. Following the transaction, the chief operating officer now owns 7,038 shares in the company, valued at approximately $580,635. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Kathleen A. Gilmartin bought 2,000 shares of the stock in a transaction on Tuesday, September 3rd. The shares were acquired at an average cost of $86.09 per share, for a total transaction of $172,180.00. Following the completion of the transaction, the director now directly owns 18,904 shares of the company's stock, valued at approximately $1,627,445.36. The trade was a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.70% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On U.S. Physical Therapy

A number of institutional investors have recently modified their holdings of USPH. Norden Group LLC boosted its position in shares of U.S. Physical Therapy by 37.5% in the first quarter. Norden Group LLC now owns 4,528 shares of the company's stock valued at $511,000 after acquiring an additional 1,235 shares during the period. BNP Paribas Financial Markets raised its position in shares of U.S. Physical Therapy by 6.8% during the first quarter. BNP Paribas Financial Markets now owns 7,837 shares of the company's stock valued at $885,000 after buying an additional 502 shares during the last quarter. GSA Capital Partners LLP lifted its stake in shares of U.S. Physical Therapy by 110.3% in the first quarter. GSA Capital Partners LLP now owns 7,909 shares of the company's stock valued at $893,000 after buying an additional 4,149 shares during the period. Texas Permanent School Fund Corp grew its position in U.S. Physical Therapy by 1.3% during the first quarter. Texas Permanent School Fund Corp now owns 13,116 shares of the company's stock worth $1,480,000 after buying an additional 170 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. bought a new position in U.S. Physical Therapy during the first quarter valued at about $391,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.